Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 12,500 shares, a decrease of 28.2% from the September 30th total of 17,400 shares. Based on an average daily trading volume, of 29,900 shares, the days-to-cover ratio is currently 0.4 days.
Arch Therapeutics Stock Performance
Shares of OTCMKTS ARTH opened at $0.39 on Friday. The company has a 50 day simple moving average of $0.49 and a two-hundred day simple moving average of $0.82. Arch Therapeutics has a 12 month low of $0.17 and a 12 month high of $18.00.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last posted its earnings results on Monday, August 19th. The biotechnology company reported ($1.44) earnings per share (EPS) for the quarter. The company had revenue of $0.03 million for the quarter.
About Arch Therapeutics
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Further Reading
- Five stocks we like better than Arch Therapeutics
- Market Cap Calculator: How to Calculate Market Cap
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Are Penny Stocks a Good Fit for Your Portfolio?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
